# Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization

> **NCT07323329** · PHASE2,PHASE3 · RECRUITING · sponsor: **Beni-Suef University** · enrollment: 165 (estimated)

## Conditions studied

- Infertility
- Infertility (IVF Patients)

## Interventions

- **DRUG:** Somatropin (4IU for 1 month) plus, folic acid 400 mcg per day.
- **DRUG:** DHEA plus folic acid 400mcg per day
- **DIETARY_SUPPLEMENT:** control group

## Key facts

- **NCT ID:** NCT07323329
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-10
- **Primary completion:** 2026-10-15
- **Final completion:** 2026-11-12
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07323329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07323329, "Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07323329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*